TRAF7 inhibits proliferation and migration of esophageal squamous cell carcinoma by ubiquitination-mediated degradation of SOX12
Biochemistry and Cell Biology · 2025
DOI: 10.1139/bcb-2024-0279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2025. Verfasst von Guobin Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Respiratory Diseases, Jiangxi Institute of Respiratory Diseases, The Department of Thoracic Surgery, The First A…. Hauptthemen laut MEDLINE: Ubiquitination, Cell Proliferation, Cell Movement, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Foundation of Jiangxi Education Department, The Natural Science Foundation of Jiangxi Province, Youth Talent Research and Cultivation Fund of the First Affiliated Hospital of Nanchang University.
Abstract (Originalsprache)
Tumor necrosis factor receptor-associated factor 7 (TRAF7), a member of the tumor necrosis factor receptor superfamily, is known as an E3 ubiquitin ligase and has been shown to contribute to the progression of various cancers. However, the function of TRAF7 in esophageal squamous cell carcinoma (ESCC) remains unclear. Here, our findings demonstrate a marked downregulation of TRAF7 protein expression in ESCC cell lines compared to non-neoplastic esophageal epithelial cells. Overexpression of TRAF7 inhibited cell proliferation and migration of ESCC cells, as well as promoted cell apoptosis and blocked cell cycle at the G2/M phase. In this study, we observed that TRAF7 interacted with the SOX12 protein and promoted ubiquitin-proteasome-mediated degradation of SOX12 via K48-linked ubiquitination in ESCC cells. Rescue experiments further confirmed that TRAF7’s inhibitory effects on tumor cell proliferation and migration in ESCC cells partly depended on SOX12. In summary, our research reveals that TRAF7 functions as a tumor suppressor partially by promoting K48-linked ubiquitination-mediated degradation of the SOX12 protein.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi Provincial Key Laboratory of Respiratory Diseases, Jiangxi Institute of Respiratory Diseases, The Department of Thoracic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanc…
- The Department of Cardiothoracic Surgery, Ji'an Central People's Hospital, Ji'an 343000, China.
ORCID-Profile: Jiangbo Jin
Förderung
- The Foundation of Jiangxi Education Department
- The Natural Science Foundation of Jiangxi Province
- Youth Talent Research and Cultivation Fund of the First Affiliated Hospital of Nanchang University
- The Science and Technology Plan Project of Jiangxi Provincial Health Commission
Zitieren
APA
Xie, G., Wang, N., Huang, Y., Yang, L., Zeng, S., & Jin, J. (2025). TRAF7 inhibits proliferation and migration of esophageal squamous cell carcinoma by ubiquitination-mediated degradation of SOX12. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2024-0279
Vancouver
Xie G, Wang N, Huang Y, Yang L, Zeng S, Jin J. TRAF7 inhibits proliferation and migration of esophageal squamous cell carcinoma by ubiquitination-mediated degradation of SOX12. Biochemistry and Cell Biology. 2025. doi:10.1139/bcb-2024-0279
BibTeX
@article{Xie2025,
author = {Xie, Guobin and Wang, Ning and Huang, Yunhe and Yang, Lun and Zeng, Shanggan and Jin, Jiangbo},
title = {TRAF7 inhibits proliferation and migration of esophageal squamous cell carcinoma by ubiquitination-mediated degradation of SOX12},
journal = {Biochemistry and Cell Biology},
year = {2025},
doi = {10.1139/bcb-2024-0279}
}
EUVIMED